A Study Of Diflucan In Children With Ringworm Of The Scalp

PHASE3CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

March 31, 2003

Conditions
Tinea Capitis
Interventions
DRUG

fluconazole

Fluconazole oral suspension 6 mg/kg/day for 6 weeks followed by 4 weeks without treatment

Trial Locations (31)

23507

Pfizer Investigational Site, Norfolk

27529

Pfizer Investigational Site, Garner

27609

Pfizer Investigational Site, Raleigh

29464

Pfizer Investigational Site, Mt. Pleasant

30907

Pfizer Investigational Site, Martinez

33156

Pfizer Investigational Site, Miami

36116

Pfizer Investigational Site, Montgomery

37130

Pfizer Investigational Site, Murfreesboro

37215

Pfizer Investigational Site, Nashville

37927

Pfizer Investigational Site, Knoxville

43205

Pfizer Investigational Site, Columbus

44106

Pfizer Investigational Site, Cleveland

48201

Pfizer Investigational Site, Detroit

55432

Pfizer Investigational Site, Fridley

60202

Pfizer Investigational Site, Evanston

60630

Pfizer Investigational Site, Chicago

63044

Pfizer Investigational Site, Bridgeton

70056

Pfizer Investigational Site, Gretna

70119

Pfizer Investigational Site, New Orleans

71105

Pfizer Investigational Site, Shreveport

72205

Pfizer Investigational Site, Little Rock

77056

Pfizer Investigational Site, Houston

78205

Pfizer Investigational Site, San Antonio

78224

Pfizer Investigational Site, San Antonio

78229

Pfizer Investigational Site, San Antonio

92123

Pfizer Investigational Site, San Diego

99717

Pfizer Investigational Site, Ponce

33156-7712

Pfizer Investigational Site, Miami

11203-2098

Pfizer Investigational Site, Brooklyn

00985

Pfizer Investigational Site, Carolina

00717-2115

Pfizer Investigational Site, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00645242 - A Study Of Diflucan In Children With Ringworm Of The Scalp | Biotech Hunter | Biotech Hunter